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Abstract
Enterobacteriaceae with blaNDM-7 is only infrequently observed. Self-
transmissible plasmids carrying the blaNDM gene increase the
dissemination of carbapenem resistance in developing countries.
This study investigates the whole genome sequence of a blaNDM-
7-positive Escherichia coli. The isolate was an extended-spectrum
β-lactamase producer by combined disc diffusion test and
carbapenemase producer by CarbaNP method. Sequencing
results revealed the isolate as E. coli ST-167 with IncX3 plasmid
carrying blaNDM-7 in addition to blaTEM-1 and blaCMY-42 genes. The
identiﬁcation of IncX3-blaNDM-7 combination is the ﬁrst report in
India where blaNDM-7 is known to cause higher resistance to
carbapenems compared to its variants.
© 2017 The Authors. Published by Elsevier Ltd on behalf of
European Society of Clinical Microbiology and Infectious Diseases.
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Introduction
Extended-spectrum β-lactamase (ESBL)-producing organisms
pose unique challenges in community and clinical settings.
Carbapenems are known to be promising drugs for ESBL-
producing organisms, but increasing resistance to carbape-
nems among Enterobacteriaceae has been reported. The prev-
alence of carbapenem-resistant Enterobacteriaceae in India has
been reported to vary from 7 to 51%. Carbapenem-resistant
Enterobacteriaceae has been associated with high mortality and
morbidity rates of 40 to 50% [1].
New Delhi metallo-β-lactamase (NDM) protein has an
extensive pattern of spread as a result of its plasmid location.
blaNDM-1 is the most prevalent variant among Enterobacteriaceae.
However, blaNDM-4, blaNDM-5, blaNDM-7 and blaNDM-14 were re-
ported to have enhanced hydrolytic activity compared to blaNDM-
1, although only a few cases were reported. Further, a wide range
of Gram-negative genera containing diverse blaNDM-harbouring
plasmids has been reported in >15 countries worldwide [2]. The
various plasmid-borne blaNDM are listed in Table 1.
Several studies have reported blaNDM-1-carrying IncX3
plasmid in Enterobacteriaceae. The IncX3 plasmids carrying
blaNDM-1 or blaNDM-5 were found to have identical backbones
[9]. Therefore, patients infected or colonized with bacteria
containing blaNDM-7 IncX3 plasmids will pose challenges to
infection control compared to other blaNDM variants [11].
Spread of antimicrobial resistance through plasmid has
become common but is difﬁcult to track. Outbreaks due to
plasmid often go undetected, as this may occur among different
genera or species. Thus, tracking is of greater medical impor-
tance to prevent the spread among other genera or species.
Speciﬁc molecular techniques like next-generation sequencing
will be handy to identify such plasmids. We report the draft
genome sequence of blaNDM-7-carrying, IncX3-positive Escher-
ichia coli isolated from clinical blood specimen.
Methods
Bacterial strains
In total 773 E. coli isolates were obtained from blood specimen
during the study period of January to December 2014. A total
of 15.7% (n = 122) of these isolates were carbapenem resistant,
of which a multidrug-resistant E. coli isolate (B37305) positive
for blaNDM was selected for whole genome sequencing. The
selected isolate was obtained from a patient, aged 65 years, who
experienced complications related to a gallbladder carcinoma,
who obtained care at Christian Medical College, Vellore, India.
Antimicrobial susceptibility testing
The isolate was screened for antimicrobial susceptibility by the
disc diffusion method using cefotaxime (30 μg), ceftriaxone
(30 μg), ceftazidime (30 μg), cefepime (30 μg), piperacillin/
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tazobactam (100/10 μg), cefoperazone/sulbactam (75/30 μg),
amikacin (30 μg), netilmicin (30 μg), gentamicin (10 μg), cip-
roﬂoxacin (5 μg), imipenem (10 μg) and meropenem (10 μg)
according to Clinical and Laboratory Standards Institute (CLSI)
2014 guidelines [12]. Quality control strains used were E. coli
ATCC 35218 for ampicillin and E. coli ATCC 25922 for rest of
the antibiotics. The combined disc method of cefotaxime with/
without clavulanic acid for ESBL production was performed as
recommended by CLSI 2014 [12]. Carbapenemase production
was tested by the CarbaNP method as recommended by CLSI
2015 [13].
CarbaNP test for detection of carbapenemase
The isolate was subjected to classical CarbaNP test using BPERII
lysis; protocol was followed as previously described by Dortet
et al. [14].
Multiplex PCR for screening of β-lactamase genes
Multiplex PCR for detection of ESBL genes blaTEM, blaSHV, blaPER
and blaVEB were performed as mentioned previously [15].
AmpC (blaMOX, blaCIT, blaDHA, blaACC, blaEBC, blaFOX) and
blaCTX-M-1 were tested using primers described earlier [16,17].
Class A, B and D carbapenemase genes were screened by
testing (blaKPC, blaGES, blaSPM, blaIMP, blaVIM, blaNDM and blaOXA-
48-like) [14,15,17–19].
Whole genome sequencing
The genome was sequenced using Ion torrent (PGM; Life
Technologies, Carlsbad, CA, USA) with 200 bp chemistry.
Isolation of genomic DNA was performed using QIAamp DNA
mini kit (Qiagen, Hilden, Germany). The sequencing was per-
formed as per the manufacturer’s instructions.
Downstream bioinformatics analysis
Data obtained were assembled de novo using AssemblerSPAdes
4.4.0.1 software in Torrent suite server version 4.4.3. The
sequence was annotated using Rapid Annotation using Subsys-
tem Technology (RAST) pipeline [20–22] (http://rast.nmpdr.
org/); PATRIC, the bacterial bioinformatics database and anal-
ysis resource [23] (http://www.patricbrc.org); and the National
Center for Biotechnology Information Prokaryotic Genomes
Automatic Annotation Pipeline (PGAAP; http://www.ncbi.nlm.
nih.gov/genomes/static/Pipeline.html). Downstream analysis
was performed using the CGE server (http://www.cbs.dtu.dk/
services), RAST and PATRIC.
Results
Phenotypic characterization
The isolate B37305 was phenotypically resistant to gentamicin,
piperacillin/tazobactam, cefoperazone/sulbactam, imipenem,
meropenem, cefotaxime, ceftriaxone, ceftazidime and cefepime,
and susceptible to amikacin, netilmicin and ciproﬂoxacin. The
carbapenem resistance was conﬁrmed by the CarbaNP test,
and the isolate was phenotypically positive for ESBL production.
Molecular characterization
On the basis of these results, the multidrug-resistant E. coli
(B37305) was selected for whole genome sequencing to identify
the molecular mechanism behind the resistance pattern and the
associated genes. The whole genome shotgun sequence has
been deposited at DDBJ/ENA/GenBank under accession num-
ber LSAQ00000000. The version described here is version
LSAQ01000000.
The strain was identiﬁed to be sequence type ST-167 using
MLST 1.8 in the CGE server [24]. Presence of antimicrobial
resistance genes such as blaNDM-7, blaTEM-1B and blaCMY-42 were
identiﬁed using the ResFinder 2.1 tool [25]. A self-transferable
IncX3 plasmid was identiﬁed using PlasmidFinder 1.3 [26]. The
TABLE 1. Diverse NDM-harbouring plasmids and their origin
Country Organism Plasmid NDM variant Reference
Japan Escherichia coli IncA/C NDM-1 Sekizuka et al. [3]
France Enterobacteriaceae IncL/M,
IncFII,
IncA/C
NDM-1 Potron et al. [4]
France E. coli IncFII NDM-1 Bonnin et al. [5]
Germany E. coli IncX3 NDM-7 Gottig et al. [6]
India Enterobacteriaceae IncF, IncA/C NDM-1, -5,
-6, -7
Rahman et al. [7]
India Klebsiella pneumoniae IncX3 NDM-5 Krishnaraju et al. [8]
China E. coli IncX3 NDM-5 Yang et al. [9]
China K. pneumoniae/
Raoultella planticola
IncX3 NDM-1 Qu et al. [10]
Canada Enterobacteriaceae IncX3 NDM-7 Chen et al. [11]
NDM, New Delhi metallo-β-lactamase.
FIG. 1. Schematic representation of genetic environment of NDM-7. blaNDM-7 is shown in black. ble, gene encoding bleomycin resistance protein;
dsbD, gene encoding oxidoreductase DsbD superfamily protein, followed by resolvase; ISEc8, insertion sequence and transposase; ORF, open reading
frame; parA, partitioning protein; trp1, gene encoding putative phosphoribosylanthranilate isomerase. Upstream of blaNDM-7 has yhhI, transposase, and
ISEc26, insertion sequence.
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genetic environment of blaNDM-7 is depicted in Fig. 1. In addi-
tion, the PATRIC analysis revealed the presence of two β-lac-
tamase enzymes that were previously reported as blaEC family
class C β-lactamases (GenBank accession no. WP_039000307).
Discussion
Carbapenem resistance among Enterobacteriaceae is becoming a
major problem, as this drug is known as being the therapy of
last resort for serious infections caused by Gram-negative
bacteria. As reported earlier, NDM is endemic to the Indian
subcontinent but has spread worldwide. The prevalence rates
of NDM-producing Enterobacteriaceae in India were found to be
5 to 18.5% [14]. E. coli–producing NDM carbapenemase have
also been reported in Canada and Cameroon, as well as other
Asian and European countries [27].
Further, the spread of ESBL producers is an important
driving force for usage of carbapenems, which enhances the
selection of carbapenemase producers [14]. The present
study provides evidence that carbapenemase producers are
often multidrug resistant and also coexpresses other anti-
biotic resistance genes which might be carried by the same
plasmid.
In addition, Dortet et al. [14] reported the presence of an
blaNDM-7 variant in E. coli. Similarly, a previous study from the
literature investigated the ﬁrst identiﬁcation of blaNDM-7 in
E. coli ST-167 [27]. There was a previous report of IncX3
plasmid carrying blaNDM-5 from India [8]. However, the iden-
tiﬁcation of IncX3 carrying blaNDM-7 is the ﬁrst to be so
described in India.
This study emphasizes the importance of screening for
blaNDM-7 and its associated plasmids. Because the IncX3 plasmid
is known for its self-transmissible properties, association of
blaNDM-7 with IncX3 enhances the dissemination potential.
Further studies on expression levels of blaNDM-7 relating to
severity of infection and patient outcome need to be conducted
in order to better understand infection control.
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